Delivery Order SPE2DB20D3505-SPE2DB22FT7Q4
- Not listed
- This federal contract award is for the delivery of INFANRIX DTAP SYRINGE 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,769.40 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The contract has an ultimate completion date of September 25, 2024. Amerisourcebergen holds a significant indefinite delivery contract (IDC) with the DLA Troop Support Medical valued at up to...
- This federal contract award is for the delivery of INFANRIX DTAP SYRINGE 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $1,636.31, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on February 28, 2024, with a completion date of February 29, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award is for the delivery of INFANRIX DTAP SYRINGE 0.5ML to the Defense Logistics Agency (DLA), a defense agency. The $4,423.50 firm fixed-price contract was awarded on May 13, 2024 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The contract has an ultimate completion date of May 14, 2024 and is not a set-aside. Amerisourcebergen Drug Corp, through its Corporate Office Division, is a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,391.22 firm fixed-price delivery order is for the supply of INFANRIX DTAP SYRINGE 0.5ML, a vaccine product. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award is for the delivery of INFANRIX DTAP SYRINGE 0.5ML to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $1,332.30, was awarded to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has no set-aside designation, indicating open competition. The award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and...
- This is a $2,064.30 delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of INFANRIX DTAP SYRINGE 0.5ML. The delivery order has an ultimate completion date of August 2, 2024 and is a firm-fixed-price contract. This award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical for delivering a comprehensive range of...
- This federal contract award, valued at $1,769.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4565804930 INFANRIX DTAP SYRINGE 0.5ML, with a completion date of September 16, 2024. This is a Firm Fixed Price Delivery Order contract, and there is no set-aside designation. Amerisourcebergen Drug Corp is a for-profit organization registered in the System for Award Management (SAM.gov) and...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of INFANRIX DTAP SYRINGE 0.5ML, a vaccine product, with a ceiling value of $1,545.80 and a period of performance through May 1, 2025. The contract is not set-aside and was awarded on April 30, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,949.00 firm-fixed-price delivery order contract covers the supply of INFANRIX DTAP SYRINGE 0.5ML medical products. The contract has an ultimate completion date of August 21, 2024. While the original solicitation was not provided, the contract appears to be part of a larger Indefinite Delivery Contract (IDC)...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of INFANRIX DTAP SYRINGE 0.5ML. The $2,949.00 fixed-price contract has a completion date of September 25, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC enables the company to...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB22FT7Q4Delivery Order
This federal contract award is for the delivery of INFANRIX DTAP SYRINGE 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $2,825.00 fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on May 6, 2022, with a completion date of May 9, 2022. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This IDC serves as the primary vehicle for AmerisourceBergen to efficiently deliver critical medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, and test kits, to the Department of Defense and other federal healthcare beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 5/6/22 |